Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00009178
Status:
COMPLETED
Last Update Posted:
2010-01-14
First Post:
2001-01-23
Brief Title:
Treatment of Bulimia Nervosa in a Primary Care Setting
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Organization:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2010-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Bulimia Nervosa is a frequent problem for young women It is widely assumed that this disorder cannot be treated effectively in a primary care setting This assumption has never been tested empirically and is probably incorrect
In the last 15 years effective treatment interventions for Bulimia Nervosa have been developed and validated in specialized treatment centers The broad aim of this proposal is to examine whether these treatments suitably adapted can be usefully transferred to general health care settings Specifically the proposed study will determine the relative and combined effectiveness of the two leading treatments for Bulimia Nervosa in a primary care setting The two major interventions are treatment with an antidepressant medication fluoxetine and with a form of cognitive behavioral therapy guided self-help designed for use in primary care
In the last 15 years effective treatment interventions for Bulimia Nervosa have been developed and validated in specialized treatment centers The broad aim of this proposal is to examine whether these treatments suitably adapted can be usefully transferred to general health care settings Specifically the proposed study will determine the relative and combined effectiveness of the two leading treatments for Bulimia Nervosa in a primary care setting The two major interventions are treatment with an antidepressant medication fluoxetine and with a form of cognitive behavioral therapy guided self-help designed for use in primary care
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01DK053635-03 | NIH | None | httpsreporternihgovquickSearchR01DK053635-03 |